Lexology April 18, 2024
Fenwick & West LLP

Click here to listen to the audio.

In this episode, Dr. Bob Schafer, CEO of Lumos Labs, discusses the company’s evolution from the popular brain training platform, Lumosity, to a leader in the development of digital therapeutics for the brain. Lumos Labs is pioneering the use of science-backed gameplay to tackle cognitive issues associated with conditions like ADHD.

This episode covers:

  • The unique dataset behind Lumosity, with over 100 million users and 8 billion gameplays
  • How their extensive research fueled the shift towards digital therapeutics
  • Challenges faced by early digital therapeutic companies,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Conferences / Podcast, Digital Health, Patient / Consumer, Provider, Technology, Trends
Related Articles:
Telehealth, Hybrid Care Increase EHR Strain For Doctors
Enhancing Global Mental Health Care With Digital Tools and AI for Scalable Interventions
Providence Spins Out Praia Health with $20M in Oversubscribed Series A Funding Led by Frist Cressey Ventures to Scale New Consumer Platform for Health Care
Telehealth Takes Center Stage With ATA Nexus
ATA Meeting Showcases Telehealth's Changing Landscape

Share This Article